BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2412536)

  • 1. Modified neck dissection for metastatic testicular carcinoma.
    Zeph RD; Weisberger EC; Einhorn LH; Williams SD; Lingeman RE
    Arch Otolaryngol; 1985 Oct; 111(10):667-72. PubMed ID: 2412536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular carcinoma metastatic to the neck.
    Lee JT; Calcaterra TC
    Am J Otolaryngol; 1998; 19(5):325-9. PubMed ID: 9758182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of neck dissection for metastatic nonseminomatous testicular carcinoma: case report and literature review.
    O'Connor A; Dias A; Timon C
    J Laryngol Otol; 2013 Oct; 127(10):1038-9. PubMed ID: 24124914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
    Javadpour N; McIntire KR; Waldmann TA; Scardino PT; Bergman S; Anderson T
    J Urol; 1978 Jun; 119(6):759-62. PubMed ID: 77918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
    Kausitz J; Hupka S; Ondrus D; Michalko J
    Int Urol Nephrol; 1988; 20(2):147-9. PubMed ID: 2454896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers in testicular tumors.
    Narayana AS; Loening S; Weimar G; Culp DA
    J Urol; 1979 Jan; 121(1):51-3. PubMed ID: 83396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neck mass as the first presentation of testicular choriocarcinoma.
    Ahmadi SA; Tavakoli H; Samadi N
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):290-2. PubMed ID: 16267684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical lymph node dissection for metastatic testicular cancer.
    van Vledder MG; van der Hage JA; Kirkels WJ; Oosterhuis JW; Verhoef C; de Wilt JH
    Ann Surg Oncol; 2010 Jun; 17(6):1682-7. PubMed ID: 20333552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
    Subramanian VS; Gilligan T; Klein EA
    Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
    Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
    Ann Intern Med; 1979 Mar; 90(3):373-85. PubMed ID: 85422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of computed tomography and serum tumor markers in metastatic retroperitoneal testicular tumor.
    Javadpour N; Doppman JL; Bergman SM; Anderson T
    J Comput Assist Tomogr; 1978 Apr; 2(2):176-80. PubMed ID: 81218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic and diagnostic applications of the growth of testicular cancer in soft agar.
    Foster BJ; Javadpour N; Ozols RF
    Int J Cell Cloning; 1983 Apr; 1(1):2-14. PubMed ID: 6201566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.